Inflammation unfolds in a sequence of overlapping stages, beginning with the body detecting a threat and ending, ideally, with tissue repair. The standard framework divides the process into recognition, vascular response, immune cell recruitment, pathogen clearance, active resolution, and rebuilding. What surprises most people is that shutting inflammation down is not passive. The body manufactures specific molecules whose entire job is to halt the inflammatory process, and when that active shutdown fails, chronic disease often follows.
How Inflammation Starts
The first stage is detection. Your immune system relies on sensor molecules embedded in the surfaces of cells, collectively called pattern recognition receptors. These sensors scan for molecular signatures that signal danger: fragments of bacterial cell walls, viral genetic material, or molecules released from your own damaged cells. When a receptor locks onto one of these danger signals, it triggers a cascade of chemical alarms inside the cell, ultimately switching on genes that produce inflammatory mediators like cytokines and chemokines.1PubMed. Pattern recognition receptors and inflammation
This system does not distinguish perfectly between foreign invaders and your own tissues. The same receptors that detect bacterial molecules can also respond to misfolded proteins or cellular debris from injuries where no infection is present. In the brain, for example, clumps of amyloid-beta protein can activate these same sensors in glial cells, triggering an inflammatory response even though no pathogen is involved.2PubMed. Inflammation in Alzheimer’s disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors That quirk is one reason inflammation plays a role in conditions like Alzheimer’s disease, not just infections and injuries.
The Vascular Response
Within seconds to minutes of detection, the blood vessels near the site of injury or infection begin to change. Chemical mediators, particularly histamine, cause small arteries to widen and the walls of tiny venules to become leaky. Intravital imaging studies have shown that histamine simultaneously dilates blood vessels, increases blood flow, and opens gaps between the cells lining small veins.3PubMed Central. Histamine Induces Vascular Hyperpermeability by Increasing Blood Flow and Endothelial Barrier Disruption In Vivo
Those gaps form because the protein that normally glues endothelial cells together, called VE-cadherin, gets tagged for removal from the cell surface. When histamine or other inflammatory signals hit the blood vessel lining, VE-cadherin is pulled inward, loosening the seal between cells and allowing fluid and proteins to seep out of the bloodstream into surrounding tissue.4PubMed Central. Ubiquitination of VE-cadherin regulates inflammation-induced vascular permeability in vivo This is the mechanism behind the swelling and warmth you feel at an injury site. The leaked fluid, called exudate, delivers antibodies and clotting factors to the damaged area while physically diluting toxins.
The Four Cardinal Signs
The vascular stage produces the classic signs of inflammation that physicians have recognized for centuries: redness, heat, swelling, and pain.5The Journals of Gerontology: Series A. The Five Cardinal Signs of Inflammation: Calor, Dolor, Rubor, Tumor … and Penuria Redness and heat come from increased blood flow to the area. Swelling comes from the fluid leaking out of permeable vessels. Pain results from pressure on nerve endings and from direct activation of pain receptors by inflammatory chemicals like bradykinin and prostaglandins.
A fifth sign, loss of function, was added later and makes intuitive sense: a swollen, painful joint does not move well, and a congested lung does not exchange gas efficiently. These signs are not the disease itself. They are evidence that the immune system is actively working, and they serve protective purposes. The swelling creates a physical barrier that slows the spread of pathogens. The pain discourages you from using the injured area, giving it time to heal. The heat makes the local environment less hospitable to certain microbes.
Immune Cell Recruitment
While the vascular changes set the stage, the real workhorses of inflammation are the white blood cells that arrive at the site. Neutrophils are typically first on the scene, drawn by chemical gradients of chemokines streaming out from the damaged tissue. Getting them from the bloodstream into the tissue is an elaborate, multi-step process: the neutrophils first roll along the inner surface of the blood vessel, then stick firmly to the vessel wall, then crawl along it until they find a spot to squeeze through to the other side.6PubMed Central. Mechanism of Diapedesis: Importance of the Transcellular Route
Once in the tissue, neutrophils attack pathogens by engulfing them, releasing toxic enzymes, or casting out nets of their own DNA to trap bacteria. They are aggressive, short-lived cells. Most survive only hours to a day or two after arriving. Their rapid die-off is actually part of the plan, because the next stage depends on cleaning them up.
Monocytes follow the neutrophils, arriving somewhat later and maturing into macrophages once they reach the tissue. Macrophages are more versatile: they engulf pathogens, present fragments of those pathogens to other immune cells to coordinate a broader response, and produce cytokines that either amplify or dampen inflammation depending on the signals they receive.
Clearance and the Pivot Toward Resolution
Once the initial threat is handled, the tissue is littered with dead neutrophils, pathogen debris, and damaged cells. If this mess is not cleaned up, the dead neutrophils will rupture and spill their toxic contents into the surrounding tissue, prolonging the damage. Macrophages step in to engulf these apoptotic neutrophils in a process called efferocytosis, and this cleanup does something remarkable: it actively flips the macrophages from a pro-inflammatory mode to an anti-inflammatory one.7PubMed Central. Clearance of apoptotic neutrophils and resolution of inflammation
This transition is critical. In the lungs, for instance, macrophages that engulf dead neutrophils begin producing signals that suppress further immune activation rather than stimulate it.8PubMed Central. STAT6 induces expression of Gas6 in macrophages to clear apoptotic neutrophils and resolve inflammation The cleanup itself becomes the signal to stand down. This is one of the more elegant features of the inflammatory process: the same cells that drive the attack also trigger its termination, but only after they have physically consumed the evidence that the attack is no longer needed.
Active Resolution Is Not Just Inflammation Fading Away
For decades, researchers assumed inflammation simply petered out once the threat was gone, like a fire running out of fuel. That understanding has changed. Resolution turns out to be an active, programmed process driven by specialized lipid mediators that the body synthesizes specifically to shut inflammation down.
The shift begins when the same prostaglandins that drove early inflammation trigger neutrophils to change the type of lipid signals they produce. This “lipid mediator class switch” moves the chemical environment from one dominated by molecules that attract more immune cells to one dominated by molecules that halt recruitment and promote tissue repair. Three families of these pro-resolving mediators have been identified: resolvins, protectins, and maresins.9JCI Insight. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators Resolvins, for example, act as a stop signal for neutrophil migration while simultaneously stimulating macrophages to clean up debris. Protectins help shield tissues from collateral damage. Maresins promote the macrophage activity needed for tissue rebuilding.
This discovery has reframed how scientists think about chronic inflammatory diseases. The problem in many of these conditions may not be too much inflammation at the start, but a failure of resolution at the end.
Tissue Repair and Rebuilding
Once the inflammatory environment quiets, the body shifts into repair. Macrophages transition from their early, aggressive state to a reparative state that promotes tissue regeneration.10PubMed Central. Controlled M1-to-M2 transition of aged macrophages by calcium phosphate coatings These reparative macrophages release growth factors that stimulate fibroblasts to lay down new structural proteins.
The repair process has its own internal timing. During the early phase, enzymes break down and clear away damaged structural proteins. In later stages, that enzymatic activity is suppressed so that new structural proteins, including collagen, can be deposited stably. Growth factors within the tissue activate fibroblasts to produce collagen that strengthens and restores elasticity to the healing area.11ScienceDirect (Elsevier). Mechanisms of skin wound healing regulated by fibroblast-derived exosomes – Section: Promotion of extracellular matrix remodeling This timing matters: if the cleanup enzymes stay active too long, they chew through the new tissue as fast as it is laid down. If collagen production goes unchecked, the result is a thick scar rather than functional tissue.
The Systemic Response
When inflammation is limited to a small area, most of the action stays local. But significant infections or injuries trigger a body-wide response. The liver ramps up production of acute-phase proteins, a family of molecules that circulate through the blood and help coordinate the immune system at a distance. In mouse models of sepsis, eliminating the liver’s ability to produce these proteins dramatically increased mortality even when the body was still clearing bacteria normally, suggesting that these proteins are essential for keeping the systemic inflammatory response from spiraling out of control.12PubMed Central. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function
Fever is another systemic manifestation. Cytokines produced at the site of inflammation travel through the bloodstream and act on the brain’s temperature-regulating center, raising the body’s thermostat. The elevated temperature enhances certain immune functions and makes the environment less favorable for some pathogens. C-reactive protein, one of the acute-phase proteins produced by the liver, is widely used as a clinical marker of systemic inflammation and rises rapidly in response to infection or tissue injury.13PubMed Central. Tracking Perioperative Inflammation over Time: A Prospective Observational Study on the Longitudinal Dynamics of CRP and GDF-15
When Resolution Fails and Inflammation Becomes Chronic
Everything described so far assumes the process works as designed: threat detected, response mounted, threat eliminated, resolution activated, tissue repaired. But when any of those steps stalls, inflammation can become self-perpetuating. The threat may persist, as in a chronic infection. The resolution machinery may be impaired, as seems to happen with aging and obesity. Or the initial trigger may be something the body cannot actually eliminate, like the amyloid plaques in Alzheimer’s disease.
Chronic low-grade inflammation, sometimes called “inflammaging,” is increasingly recognized as a link between aging, obesity, and a range of diseases including insulin resistance and cardiovascular disease.14PubMed Central. Aging, Obesity, and Inflammatory Age-Related Diseases Unlike the acute inflammation from a cut or infection, this chronic variety typically does not produce the dramatic cardinal signs. Instead, it simmers at low levels, detectable mainly through blood markers like elevated C-reactive protein and interleukin-6. Doctors can track these biomarkers to monitor inflammatory activity and even assess the risk of progression toward more serious disease.15American Journal of Epidemiology. Biomarkers of chronic inflammation to monitor disease progression and cancer risk
The gut microbiome plays a role in this persistent inflammation too. Bacterial metabolites from gut microbes are delivered to immune cells through the intestinal lining, and when the microbial community is disrupted, the resulting immune activation can drive inflammation both locally and throughout the body. Sustained disruption of this kind has been linked to inflammatory bowel disease, diabetes, and cardiovascular disease.16PubMed Central. The Gut Microbiota and Inflammation: An Overview – Section: Role of the Gut Microbiota in Immunity and Inflammation
When Inflammation Overshoots
At the extreme end, inflammation can become acutely dangerous. Cytokine storm syndrome occurs when the immune system’s signaling gets stuck in a positive feedback loop: dying cells release danger signals, which trigger more cytokine production, which causes more cell death, which releases more danger signals. This runaway process can cause tissue damage across multiple organs simultaneously.17PubMed Central. The ‘cytokine storm’: molecular mechanisms and therapeutic prospects Cytokine storms have been observed in severe infections, certain genetic immune disorders, and as a complication of some cancer immunotherapies. The condition gained public awareness during the COVID-19 pandemic, when severe cases were often characterized by this kind of uncontrolled inflammatory escalation.
The distinction between a healthy inflammatory response and a pathological one is largely a matter of feedback control. A well-functioning system has built-in brakes at every stage: anti-inflammatory cytokines, pro-resolving lipid mediators, macrophage phenotype switching, acute-phase proteins that regulate immune cell activity. When enough of those brakes fail simultaneously, the response that evolved to protect you becomes the thing causing harm.
How Pain Medication Interacts with These Stages
Most people’s first response to inflammation is to reach for an anti-inflammatory drug. Nonsteroidal anti-inflammatory drugs work by blocking cyclooxygenase enzymes that produce prostaglandins, the lipid signals responsible for pain, swelling, and fever. That effectively suppresses the vascular and pain stages of acute inflammation. But recent research raises a complicating question: since some of those same prostaglandins are the ones that trigger the lipid mediator class switch needed for resolution, blocking them early may actually delay healing.
Studies have found that NSAID use in the early phase of acute pain can prolong both pain and inflammation and delay their resolution.18PubMed. Rethinking the use of NSAIDs in early acute pain This does not mean you should never take ibuprofen for a sprained ankle. But it does suggest that aggressively suppressing inflammation at the very beginning of an acute injury could, in some cases, interfere with the body’s own resolution program. The clinical implications are still being worked out, and the answer likely depends on the severity and type of injury. For chronic inflammatory conditions, where the resolution process has already failed, anti-inflammatory drugs address a different problem entirely.
Why the Body Tolerates Such a Costly System
Inflammation is expensive for the body. It damages healthy tissue, diverts metabolic resources, and causes pain and disability. So why has evolution kept it around? Because in ancestral environments full of pathogens and physical trauma, the cost of not mounting a rapid inflammatory response was death from infection. The trade-off between the damage inflammation causes and the protection it provides has been shaped over millions of years for environments where infections were common and often lethal.19PubMed Central. Evolution of inflammatory diseases
The mismatch between the environment we evolved in and the one we now live in helps explain why inflammatory diseases are so common in modern life. Immune responses that enhanced survival in pathogen-dense ancestral settings carry downstream costs when they are repeatedly triggered by modern stressors like chronic psychological stress, excess caloric intake, and reduced exposure to the microorganisms that historically helped calibrate the immune system.20PubMed. The Price of Protection: Evolutionary tradeoffs in inflammatory depression The system was not designed for a world of office jobs, processed food, and constant low-grade psychological stress. It was designed for a world of infected wounds and parasitic infections, and it continues to operate by those rules.
Circadian Rhythms and Inflammatory Timing
One underappreciated factor in how inflammation plays out is the body’s internal clock. Immune cell activity fluctuates over a 24-hour cycle, with different arms of the immune system peaking at different times of day. Disruption of circadian clock machinery influences key activities in both immune response and brain function, and chronic circadian disruption has been linked to increased neuroinflammation and neurodegeneration.21PubMed Central. Circadian Clock Regulates Inflammation and the Development of Neurodegeneration
This has practical implications. Shift workers, people with irregular sleep schedules, and those with jet lag may experience altered inflammatory responses simply because their immune timing is out of sync. Some research groups are exploring whether the timing of anti-inflammatory drug administration could be optimized to align with these circadian patterns, a concept known as chronotherapy. The stages of inflammation are not just a spatial sequence unfolding at a wound site; they are also a temporal sequence tuned to the body’s daily rhythms.